garenoxacin has been researched along with Skin Diseases, Bacterial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biedenbach, DJ; Jones, RN; Kirby, JT; Mutnick, AH; Pfaller, MA | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
2 other study(ies) available for garenoxacin and Skin Diseases, Bacterial
Article | Year |
---|---|
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Indoles; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Topics: Adult; Anti-Bacterial Agents; Asia; Europe; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Latin America; Male; Microbial Sensitivity Tests; North America; Pacific Ocean; Population Surveillance; Skin Diseases, Bacterial; Soft Tissue Infections | 2007 |